Search for: "Dura Pharmaceuticals, Inc. v. Broudo" Results 21 - 40 of 59
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2013, 7:12 am
Our next post will discuss the complimentary roles of inside and outside counsel. [1] Dura Pharmaceuticals, Inc. v. [read post]
28 Jun 2013, 10:05 am
The Second Circuit rejected this argument, noting that the Supreme Court's reference to securities fraud statutes in CSX Transportation was accompanied by a citation to a civil securities fraud case (Dura Pharmaceuticals, Inc. v. [read post]
17 Apr 2010, 10:22 am by Fordham Law Review
Chase Lightening the Load: Whether the Burden of Proof for Overcoming a Patent’s Presumption of Validity Should Be Lowered Kristen Dietly The Rule 10b-5 Suit: Loss Causation Pleading Standards in Private Securities Fraud Claims After Dura Pharmaceuticals, Inc. v. [read post]
7 Jul 2009, 3:24 pm
The court also rebuffed PIMCO's "repeated, indeed obsessive, citations to the Supreme Court's decision in Dura Pharmaceuticals, Inc. v. [read post]
18 Aug 2008, 12:07 pm
The district court dismissed the class action with prejudice on the ground that plaintiffs “failed to adequately plead loss causation” under Dura Pharmaceuticals, Inc.. v. [read post]
8 Nov 2007, 5:15 am
Since the plaintiffs did not sufficiently plead loss causation, the court explained what loss causation it would consider appropriate under the standard set forth in Dura Pharmaceuticals, Inc. v. [read post]
30 Jan 2012, 9:52 am by James Hamilton
For example, should the Commission provide a loss causation standard similar to the civil loss causation standard articulated by the Supreme Court in Dura Pharmaceuticals, Inc. v. [read post]